Safety and immunogenicity of Ad26COV2S in adolescents Phase 2 randomized clinical trial
| dc.article.end-page | 13 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1080/21645515.2025.2450120 | en |
| dc.contributor.author | J Tica | en |
| dc.contributor.author | Veronica V. Rezelj | en |
| dc.contributor.author | Benoit Baron | en |
| dc.contributor.author | Vitalija van Paassen | en |
| dc.contributor.author | Lee Fairlie | en |
| dc.contributor.author | E et al | en |
| dc.date.accessioned | 2026-04-22T19:15:02Z | |
| dc.department | WITS REPRODUCTIVE HEALTH AND HIV INSTITUTE | en |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 2164-5515 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/49096 | |
| dc.journal.title | Safety and immunogenicity of Ad26COV2S in adolescents Phase 2 randomized clinical trial | en |
| dc.journal.volume | 21 | en |
| dc.title | Safety and immunogenicity of Ad26COV2S in adolescents Phase 2 randomized clinical trial | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 5.5 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client